|
|
|
|
|
|
|
|
|
|
AbCellera and AbbVie Partner to Advance New Antibody Therapies
|
Vancouver, BC, December 19, 2022--AbCellera announced that it has entered into a multi-year, multi-target strategic collaboration with AbbVie Inc. The partnership will leverage AbCellera's antibody discovery and development engine to deliver optimized development candidates for up to five targets selected by AbbVie across multiple indications.
|
|
|
|
|